Publications by authors named "Kai-Si Yang"
Article Synopsis
- - The study investigates the effectiveness and safety of anti-TNF-α monoclonal antibodies (adalimumab and infliximab) combined with proactive therapeutic drug monitoring (TDM) for patients with inflammatory bowel disease (IBD).
- - Results from 13 included studies showed that proactive TDM significantly improved clinical remission rates, reduced surgery needs, and decreased adverse events among patients, particularly those treated with adalimumab.
- - The authors conclude that proactive TDM is especially beneficial for IBD patients treated with adalimumab, suggesting a need for tailored monitoring strategies based on the patient's treatment type.